SCHEMBL26201883

SCHEMBL26201883

CO[C@@H]1[C@H](OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(=O)[nH]c(N)nc43)[C@H](O)[C@@H]2O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O[C@H]1n1cnc2c1/N=C\CC/C=C\2N

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FUT5 Q11128 1/20 0.58
TGM2 P21980 1/20 0.56
KRAS P01116 3/20 0.55
RNASEL Q05823 6/20 0.55
P2RY6 Q15077 2/20 0.52
P2RY2 P41231 1/20 0.52
P2RY4 P51582 1/20 0.52
NT5E P21589 1/20 0.52
DCPS Q96C86 1/20 0.49
P2RX3 P56373 2/20 0.49
ENPP1 P22413 2/20 0.49
P2RY1 P47900 2/20 0.49
P2RX1 P51575 1/20 0.49
P2RY11 Q96G91 1/20 0.49
P2RX4 Q99571 1/20 0.49
IMPDH2 P12268 1/20 0.48
IMPDH1 P20839 1/20 0.48
P2RY12 Q9H244 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26203966 1.00 FUT5 (0.58) FUT5TGM2KRASRNASELP2RY6
SCHEMBL26205546 0.95 FUT5 (0.55) FUT5TGM2KRASRNASELP2RY6
SCHEMBL26206026 0.91 FUT5 (0.52) FUT5TGM2KRASRNASELP2RY6
SCHEMBL26203039 0.91 FUT5 (0.52) FUT5TGM2KRASRNASELP2RY6
SCHEMBL26201436 0.89 TGM2 (0.68) FUT5TGM2KRASRNASELP2RY6
SCHEMBL26204432 0.89 TGM2 (0.68) FUT5TGM2KRASRNASELP2RY6
SCHEMBL26214732 0.88 FUT5 (0.51) FUT5TGM2KRASP2RY6P2RY2
SCHEMBL26201635 0.88 FUT5 (0.57) FUT5TGM2KRASRNASELP2RY6
SCHEMBL26201726 0.88 FUT5 (0.57) FUT5TGM2KRASRNASELP2RY6
SCHEMBL26207956 0.88 FUT5 (0.56) FUT5TGM2KRASRNASELP2RY6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023159930-A1 COMPOUND FOR RNA CAPPING AND APPLICATION OF COMPOUND 广州市恒诺康医药科技有限公司 2023-08-31 WO disclosed